Establishment of a Nomogram-Based Prognostic Model (LASSO-COX Regression) for Predicting Progression-Free Survival of Primary Non-Small Cell Lung Cancer Patients Treated with Adjuvant Chinese Herbal Medicines Therapy: A Retrospective Study of Case Series.

Luo, Bin; Yang, Ming; Han, Zixin; Que, Zujun; Luo, Tianle; Tian, Jianhui

Luo, Bin; Yang, Ming; Han, Zixin; Que, Zujun; Luo, Tianle; Tian, Jianhui.

Afiliación

Luo B; Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Yang M; Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Han Z; Department of Good Practice Criterion, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Que Z; School of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Luo T; Cancer Institute of Traditional Chinese Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Tian J; Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Front Oncol ; 12: 882278, 2022.

Article en En | MEDLINE | ID: mdl-35875082

Palabras clave

Chinese herbal medicines (CHMs); nomogram; primary non-small cell lung cancer (PNSCLC); prognostic model; progression-free survival (PFS)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google